Combining Experimental and Computational Tools to Unravel Copper-Based Metallodrug Interactions With Proteins
Metallodrugs are widely used in the treatment of several diseases, including cancer. Many bloodstream proteins exhibit high affinities for metals and metal-based compounds, and these interactions have been shown to impact metallodrug pharmacokinetics and pharmacodynamics, ultimately influencing thei...
Saved in:
| Main Authors: | Quim Peña, Iker Zapirain-Gysling, A. Jalila Simaan, Mercè Capdevila, Olga Iranzo, Òscar Palacios, Jean-Didier Maréchal, Pau Bayón |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Bioinorganic Chemistry and Applications |
| Online Access: | http://dx.doi.org/10.1155/bca/5551967 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of Copper Metallodrugs as Potential Inhibitor of Cancer via Molecular Docking and DFT
by: Gopala Krishna Murthy H R, et al.
Published: (2025-05-01) -
Rhodium-based metallodrugs for biological applications: current status and future perspectives
by: Wang Xiang, et al.
Published: (2025-08-01) -
The Role of Vanadium in Metallodrugs Design and Its Interactive Profile with Protein Targets
by: Otávio Augusto Chaves, et al.
Published: (2024-10-01) -
The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs
by: Donghan Bai, et al.
Published: (2025-04-01) -
Recent advances in metallodrug: Coordination-induced synergy between clinically approved drugs and metal ions
by: Won Kyu Kim, et al.
Published: (2025-03-01)